Prothena Corp
PRTA
132 hedge funds and large institutions have $531M invested in Prothena Corp in 2014 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 50 increasing their positions, 18 reducing their positions, and 25 closing their positions.
178% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 18
56% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 25
23% more call options, than puts
Call options by funds: $6.79M | Put options by funds: $5.51M
12% more funds holding
Funds holding: 118 → 132 (+14)
36% less capital invested
Capital invested by funds: $832M → $531M (-$301M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$41.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$18.4M |
| 3 |
State Street
Boston,
Massachusetts
|
+$17M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$17M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$13.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$72.4M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$59.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$28.2M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$20.8M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$13.4M |
PRTA Hedge Fund Activity: Q2 2014 in Review
132 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Prothena Corp (PRTA) for Q2 2014, worth a combined $531M — down 36% from $832M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new PRTA positions and 25 closed out — a net gain of 14 holders — while 50 added to existing stakes and 18 trimmed.
The largest buyer was Bank of America, adding an estimated $41.2M. The largest seller was OrbiMed, exiting entirely with an estimated $72.4M sold.
- 132 institutional investors held Prothena Corp (PRTA) as of Q2 2014, up from 118 in Q1 2014.
- Funds reported $531M of Prothena Corp stock for Q2 2014, down 36% quarter-over-quarter.
- 39 funds opened new Prothena Corp positions in Q2 2014 and 25 closed out, a net change of +14 holders.
- The largest Prothena Corp buyer in Q2 2014 was Bank of America, an estimated $41.2M added.
- The largest Prothena Corp seller in Q2 2014 was OrbiMed, an estimated $72.4M sold.
Based on aggregated 13F filings for Q2 2014.